Home › Non-Small Cell Lung Cancer › Washington › Vancouver

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Vancouver, WA

9 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Vancouver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Nagre-recruitPhase 2/3

Northwest Cancer Specialists - Vancouver /ID# 277855, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07155187

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Nagre-recruitPhase 3

Compass Oncology, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06765109

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Northwest Cancer Specialists, P.C., Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Northwest Cancer Specialists PC, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Nagre-recruitPhase 3

Research Site, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06357533

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Nagre-recruitPhase 3

Clinical Study Site, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Nagre-recruitPhase 2/3

USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04613596

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

USO - Northwest Cancer Specialists, Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

MYLUNG Consortium Part 3: Observational Study

Nagre-recruitObservasyonal na pag-aaral

Northwest Cancer Specialists, P.C., Vancouver

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05885698

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Vancouver

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.